Showing 1 - 3 results of 3 for search 'Candida Guckelmus' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Candida Guckelmus
Showing 1 - 3 results of 3 for search 'Candida Guckelmus', query time: 0.03s Refine Results
  1. 1
    Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients

    Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patients by Saskia Bronder, Janine Mihm, Rebecca Urschel, Verena Klemis, Tina Schmidt, Stefanie Marx, Amina Abu-Omar, Franziska Hielscher, Candida Guckelmus, Marek Widera, Urban Sester, Martina Sester

    Published 2024-02-01
    Get full text
    Article
  2. 2
    Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens

    Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens by Verena Klemis, Tina Schmidt, David Schub, Janine Mihm, Stefanie Marx, Amina Abu-Omar, Laura Ziegler, Franziska Hielscher, Candida Guckelmus, Rebecca Urschel, Stefan Wagenpfeil, Sophie Schneitler, Sören L. Becker, Barbara C. Gärtner, Urban Sester, Martina Sester

    Published 2022-08-01
    Get full text
    Article
  3. 3
    SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals

    SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals by Rebecca Urschel, Saskia Bronder, Verena Klemis, Stefanie Marx, Franziska Hielscher, Amina Abu-Omar, Candida Guckelmus, Sophie Schneitler, Christina Baum, Sören L. Becker, Barbara C. Gärtner, Urban Sester, Leonardo Martinez, Marek Widera, Tina Schmidt, Martina Sester

    Published 2024-04-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs